Zoetis Inc (ZTS)

NYSE
186.60
+1.21(+0.65%)
After Hours
186.65
+0.05(+0.03%)
- Real-time Data
  • Volume:
    1,980,699
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    183.66 - 187.32

ZTS Overview

Prev. Close
185.39
Day's Range
183.66-187.32
Revenue
7.01B
Open
185.55
52 wk Range
131.28-187.32
EPS
3.71
Volume
1,980,699
Market Cap
88.63B
Dividend (Yield)
1.00
(0.54%)
Average Vol. (3m)
1,773,367
P/E Ratio
49.98
Beta
0.63
1-Year Change
35.81%
Shares Outstanding
474,973,405
Next Earnings Date
Jul 19, 2021
What is your sentiment on Zoetis Inc?
or
Market is currently closed. Voting is open during market hours.

Zoetis Inc News

Zoetis Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsBuySellStrong BuyStrong BuyStrong Buy
SummaryStrong BuyNeutralStrong BuyStrong BuyStrong Buy

Zoetis Inc Company Profile

Zoetis Inc Company Profile

Employees
11300

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

Read More
  • I bought in after I was offered the stock because I owned Pfizer years ago. My perspective is different because I bought in at a discount when it was under 30 dollars a share. If it takes a dip, I'll just by more. Either way I'm still have a large ROI.
    0
    • Time to offload this stock.  At least 30% decline coming
      1
      • Everything about this company looks good and I've been in with them since January but their price just can't seem to rise to their potential.  Selling off my shares of this boat anchor.
        3
        • Very intresting Stock. Who bought this?
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.